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Abstract  This  study  was  designed  to  investigate  whether  dexmedetomidine  and  thiopental
have cerebral  protective  effects  after  focal  cerebral  ischemia  in  rats.  Thirty  male  Sprague
Dawley rats  were  randomly  assigned  to  three  groups:  control  group  (Group  C,  n  =  10),
dexmedetomidine  group  (Group  D,  n  =  10),  thiopental  group  (Group  T,  n  =  10).  After  all  rats  were
anesthetized,  they  were  intubated,  then  mechanically  ventilated.  A  catheter  was  inserted  into
the right  femoral  artery  for  continuous  mean  arterial  pressure,  physiological  parameters  and
blood sampling  at  baseline,  5  min  after  occlusion  and  20  min  after  reperfusion.  A  catheter  was
inserted into  the  left  femoral  vein  for  intravenous  (IV)  medication  administration.  Right  com-
mon carotid  artery  of  each  rat  was  isolated  and  clamped  for  45  min.  At  the  end  of  the  duration
common carotid  artery  were  unclamped  and  the  brain  reperfusion  was  achieved  for  90  min.
Dexmedetomidine  was  administered  for  Group  D  IV  infusion,  and  Group  T  received  thiopental
IV. According  to  histopathologic  scores  cerebral  ischemia  was  documented  in  all  rats  in  Group  C,
but no  ischemia  was  found  in  three  rats  in  Group  T  and  in  four  rats  in  Group  D.  Grade  3  cerebral
ischemia was  documented  in  three  rats  in  Group  C,  and  in  only  one  rat  in  both  groups  T  and
D. For  histopathologic  grades  the  difference  between  Group  T  and  Group  D  was  not  signiﬁcant
(p >  0.05).  But  the  differences  between  Group  C  and  Group  T  (p  <  0.05)  and  Group  C  and  Group
D (p  <  0.01)  were  statically  signiﬁcant.  In  conclusion,  we  demonstrated  that  dexmedetomidine
and thiopental  have  experimental  histopathologic  cerebral  protective  effects  on  experimental
focal cerebral  ischemia  in  rats.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
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Comparac¸ão  histopatológica  dos  efeitos  protetores  cerebrais  de  dexmedetomidina
e  tiopental  sobre  isquemia  cerebral  focal  em  ratos
Resumo  Este  estudo  foi  desenhado  para  investigar  se  dexmedetomidina  e  tiopental  possuem
efeitos protetores  cerebrais  após  isquemia  cerebral  focal  em  ratos.  Trinta  ratos  da  linhagem
Sprague  Dawley  foram  randomicamente  alocados  em  três  grupos:  controle  (Grupo  C,  n  =  10),
dexmedetomidina  (Grupo  D,  n  =  10)  e  tiopental  (Grupo  T,  n  =  10).  Após  a  anestesia,  todos  os
ratos foram  intubados  e  ventilados  mecanicamente.  Um  cateter  foi  inserido  na  artéria  femoral
direita para  monitorac¸ão  contínua  da  pressão  arterial  média  (PAM),  dos  parâmetros  ﬁsiológicos
e para  coleta  de  amostras  de  sangue  na  fase  basal,  5  minutos  após  a  oclusão  e  20  minutos  após
a reperfusão.  Um  cateter  foi  inserido  na  veia  femoral  esquerda  para  administrac¸ão  intravenosa
(IV) de  medicamentos.  A  artéria  carótida  comum  direita  de  cada  rato  foi  isolada  e  pinc¸ada
durante 45  minutos.  Ao  ﬁnal  dos  45  minutos,  o  pinc¸amento  foi  removido  e  a  reperfusão  do
cérebro foi  obtida  por  90  minutos.  Dexmedetomidina  foi  administrada  por  infusão  IV  no  Grupo
D e  thiopental  no  Grupo  T.  De  acordo  com  as  pontuac¸ões  histopatológicas,  isquemia  cerebral
foi observada  em  todos  os  ratos  do  Grupo  C,  mas  não  foi  encontrada  em  três  ratos  do  Grupo
T e  em  quatro  ratos  do  Grupo  D.  O  grau  3  de  isquemia  cerebral  foi  observado  em  três  ratos
do grupo  C  e  em  apenas  um  rato  de  ambos  os  grupos  T  e  D.  Para  os  graus  histopatológicos,  a
diferenc¸a entre  o  Grupo  T  e  o  Grupo  D  não  foi  signiﬁcativa  (p  >  0,05).  Porém,  as  diferenc¸as  entre
o Grupo  C  e  o  Grupo  T  (p  <  0,05)  e  entre  o  Grupo  C  e  o  Grupo  D  (p  <  0,01)  foram  estatisticamente
signiﬁcativas.  Em  conclusão,  demonstramos  que  dexmedetomidina  e  tiopental  possuem  efeitos
histopatológicos  protetores  cerebrais  sobre  isquemia  cerebral  focal  experimental  em  ratos.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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t  has  been  demonstrated  by  prospective  epidemiological
tudies  conducted  in  developed  western  countries  that  cere-
rovascular  diseases  (CVDs)  are  responsible  for  10%  of  all
eaths  and  are  ranked  third  after  heart  diseases  and  cancer
s  a  cause  of  mortality.1--3 About  75%  of  CVDs  result  from
hrombotic  or  embolic  cerebral  infarcts.2,4
The  infarct  model  provided  by  occlusion  of  experimental
iddle  cerebral  artery  (MCA)  representing  the  focal  cere-
ral  infarction  which  is  the  most  common  type  of  CVD  in
linical  practice  has  been  widely  accepted.2,4,5 Rats  bear
 very  close  resemblance  to  the  human  brain  in  terms  of
erebrovascular  anatomy  and  physiology  and  thus,  they  are
idely  used  in  cerebral  ischemia  studies.3 The  validity  of  this
odel  of  cerebral  ischemia  highly  depends  on  strict  control
f  physiological  parameters  which  may  cause  ﬂuctuations
nd  changes  in  the  results  such  as  body  temperature,  blood
ressure,  blood  gases,  and  glucose  levels.4
In  clinical  use,  there  is  still  no  ideal  medication  which
ears  all  the  desired  characteristics  and  is  effective  enough
n  cerebral  ischemia.6,7 In  order  to  respond  to  clinical  needs,
n  animal  models,  a  large  number  of  agents  from  different
hemical  groups  which  is  thought  to  have  beneﬁcial  effects
n  cerebral  ischemia  are  still  being  tested  and  their  effects
n  cerebral  ischemia  are  methodologically  examined.2,4 The
ovel  molecular-level  information  on  the  pathophysiology
f  cerebral  ischemia  have  led  to  the  use  of  numerous
otential  therapeutic  agents  estimated  or  alleged  to  be
ffective  on  such  pathophysiologic  mechanisms  in  experi-
ental  studies.8,9
a
c
tThe  effects  of  barbiturates  as  well  as  the  thiopen-
al,  an  agent  mostly  used  in  anesthesia  practice  in  this
lass,  on  cerebral  blood  ﬂow  and  cerebral  metabolism  were
esearched  and  found  to  cause  a  decrease  in  cerebral  blood
ow  and  cerebral  metabolic  rate  depending  on  the  dose.
t  has  been  observed  that  cerebral  oxygen  metabolism  is
educed  by  55--60%  at  a  barbiturate  dose  causing  isoelec-
ricity  in  EEG;  however,  cerebral  metabolism  proceeded  and
he  cerebral  basal  metabolism  that  is  necessary  to  ensure
hysiological  functions  and  cell  integrity  of  neurons  did  not
epressed  through  a  further  increase  of  the  blood  barbitu-
ates  dose.10,11
There  are  different  views  about  whether  or  not  barbitu-
ates  are  neuroprotective.  In  post-traumatic  focal  cerebral
schemia;  they  are  found  to  reduce  hyperemia  by  making
 deep  depression  in  the  cerebral  metabolic  rate,  improve
he  harmony  of  ﬂow  &  metabolism,  increase  perfusion  in  the
ow-ﬂow  region  and  have  brain  protective  effect  by  mini-
ying  the  infarcted  area.12,13 Thiopental  and  methoheksital
ere  again  studied  at  different  doses  in  the  models  of  focal
erebral  ischemia  in  rats  and  were  histopathologically  shown
o  reduce  infarct  volume  at  doses  causing  burst  suppression
n  EEG.14
Dexmedetomidine  is  a  new  medication  gained  popularity
n  anesthesia  practice.  A  -2  receptor  agonist,  this  med-
cation  provides  analgesia  without  cooperative  sedation,
nxiolysis  and  respiratory  depression.  Alpha  2  adrenocep-
ors  show  a  broad  dissemination  in  cerebral  vascular  bed
nd  activation  of  these  receptors  causes  a  speciﬁc  vaso-
onstrictive  response.  Although  being  very  common  in
he  cerebral  vasculature,  their  effects  on  the  control  of
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cerebral  blood  ﬂow  and  the  cerebrovascular  reactivity  is  still
unclear.
It  has  been  observed  that  administering  dexmedetomi-
dine  in  focal  cerebral  ischemia  reduces  the  infarct  volume
in  the  cortex  by  40%  and  in  addition  to  this,  causes  min-
imal  hyperglycemia  and  hypotension.15 It  has  been  also
observed  that,  through  administration  of  dexmedetomidine
in  incomplete  cerebral  ischemia,  the  plasma  catecholamine
levels  were  decreased  and  the  histopathological  improve-
ment  became  better  than  control,  depending  on  the  dose.16
Besides,  in  terms  of  the  infarct  volume  after  temporary
occlusion  (15  mcg/kg),  a  31%  decrease  in  cortex  and  20%
decrease  in  striatum  were  reported  in  rats  given  the  high
dose  of  dexmedetomidine.17 It  has  been  also  reported
that,  while  circulating  catecholamines  were  decreasing
during  cerebral  ischemia,  the  noradrenaline  and  gluta-
mate  concentrations  in  the  brain  were  not  affected  by
dexmedetomidine.18 The  -2  adrenoceptor  subtypes  causing
neuroprotective  effects  were  reported  to  be  -2A.19
Purpose
The  purpose  of  this  study  is  to  histopathologically  study
whether  or  not  thiopental  and  dexmedetomidine  which  are
among  the  intravenous  anesthetics  have  cerebral  protective
effects  on  focal  cerebral  ischemia  in  rats.
Materials and methods
This  study  was  carried  out  in  Atatürk  University,  Experi-
mental  Medical  Research  and  Application  Center  (ATADEM)
with  permission  from  the  ethics  committee  established  by
Atatürk  University,  the  Ofﬁce  of  the  Dean  of  the  Faculty  of
Medicine.  The  ﬁve-month-old  Sprague  Dawley-type  30  male
rats  which  are  250--300  g  in  weight  were  obtained  from  ATA-
DEM.
For  the  sake  of  having  safe  and  healthy  research  results,
particular  attention  was  paid  to  select  subjects  which  were
not  used  in  a  study  before  and  were  not  exposed  to  any
medication  as  well  as  which  did  not  have  any  disease  and
were  fully  healthy  during  our  experiments.
No  subjects  included  in  the  study  were  fed  12--16  h  before
the  study  in  order  to  keep  them  hungry.  In  the  meantime,
each  subject’s  weight  was  determined  and  recorded.  Then
the  rats  were  randomly  divided  into  three  groups:  control
group  (Group  C,  n  =  10);  dexmedetomidine  group  (Group  D,
n  =  10);  thiopental  group  (Group  T,  n  =  10).
All  subjects  were  anesthetized  with  5%  isoﬂurane
(ForanefJ,  Abbott,  Istanbul,  Turkey)  in  the  glass  vase  through
the  anesthesia  machine  in  the  research  laboratory  of  ATA-
DEM.  Neck  regions  of  the  subjects  in  the  supine  position
were  shaved  and  the  sterilization  of  the  surgical  site  was
achieved.  Their  heads  were  slightly  extended  and  the  mid-
line  pretracheal  surgical  incision  was  made.  Subsequently,
the  trachea  was  intubated  (Fig.  1)  and  their  lungs  began  to
be  mechanically  ventilated.  Along  with  the  ventilation,  2%
isoﬂurane,  30%  oxygen  and  70%  nitrous  oxide  was  given  to
subjects.  Ventilation  was  applied  in  a  way  to  ﬁx  the  num-
ber  of  breaths  per  minute  to  60  and  the  tidal  volume  to
12  mL/kg.  Ventilation  was  continued  by  achieving  35  mmHg
of  end-tidal  carbon  dioxide.  A  catheter  was  inserted  into
b
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aFigure  1  One  of  the  rats  used  and  intubated  in  the  study.
he  right  femoral  artery  in  order  to  continuously  moni-
or  the  mean  arterial  pressure  and  take  blood  sample  and
nto  the  left  femoral  vein  for  medication  administration.
mmediately  after  arterial  cannulation  (basal  values);  all
hysiological  parameters  (MAP;  body  temperature)  were
ecorded  three  times  for  three  times  including  at  the  5th
inute  of  arterial  occlusion  and  20th  minutes  of  reper-
usion  and,  blood  sample  was  obtained  from  the  left  femoral
ein  in  order  to  determine  pH,  pO2, pCO2, glucose  and
ematocrit  values  in  the  arterial  blood  gas  and  sent  to  the
aboratory  of  the  Department  of  Biochemistry.5,20 Their  left
emoral  veins  were,  however,  cannulated  for  the  infusion  of
nesthetic  medications  and  heparinization.  For  the  motor-
zation  of  mean  arterial  pressure  (MAP),  a  radio-telemetry
evice  probe  was  connected  to  the  tails  of  rats.  Rats  were
tudied  on  blanket  in  order  to  keep  them  at  normother-
ic  level.15 Subsequently,  their  internal  carotid  arteries
ere  found  through  side  neck  dissection  (under  sterile
onditions)  (Fig.  2)  and  occlusion  was  achieved  by  a  vas-
ular  clamp  for  a  duration  of  45  min  (Figs.  3  and  4).  After
5  min,  the  vascular  clamp  was  opened  and  brain  reperfusion
as  achieved  for  90  min  duration.  During  occlusion  and
eperfusion,  dexmedetomidine  infusion  was  administered  to
roup  D  at  a  rate  of  9  mcg/kg/h  and  thiopental  infusion  was
dministered  to  Group  T  at  a  rate  of  140  mcg/kg/h20 while
o  intravenous  anesthetic  medication  was  administered  to
ontrol  group.  At  the  end  of  reperfusion,  0.1  mg/kg  vecuro-
ium  bromide  (Norcuron,  Roche,  Turkey)  was  administered
o  rats  in  order  to  achieve  ideal  muscle  relaxation  and  their
rains  were  duly  removed  through  temporal  craniotomy.  The
rains  were  put  into  10%  formalin  solution  in  order  to  be  sent
o  the  Department  of  Pathology  and  were  evaluated  for  an
ppropriate  histopathological  analysis.
586  
Figure  2  One  of  the  rats  to  which  a  right  carotid  artery  dis-
section was  performed.
Figure  3  The  rat  to  which  a  right  carotid  artery  occlusion  was
performed.
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migure  4  The  intubated  rat  to  which  right  carotid  artery
cclusion  was  performed  and  the  anesthesia  apparatus  used.
Immediately  after  ischemia  was  developed,  all  subjects
ere  killed  by  decapitation  under  anesthesia  and  were  sac-
iﬁced.  For  histopathological  examination,  all  the  brains
emoved  in  whole  were  treated  in  the  following  sequence:
he  brains  were  put  in  10%  phosphate-buffered  formalin
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or  duration  of  48  h.  Hippocampus  cornuammonis  1 (CA  1)
one  was  detected  (in  the  coronal  plane,  3300  m  poste-
ior  to  Bregma).  The  tissue  samples  taken  were  dehydrated
ith  ethanol  and  were  embedded  into  parafﬁn  blocks  after
assing  through  xylol;  then,  4  mm  thick  coronal  slices  were
ollected;  they  were  stained  with  hematoxylin--eosin  and
 mm  coronal  slices  were  collected,  the  analysis  was  evalu-
ted,  through  400× magniﬁcation,  by  a pathology  specialist
xperienced  in  this  ﬁeld  who  had  no  knowledge  of  the
roups.  Based  histopathologically  on  the  Nissl  substance
oss,  increase  in  cytoplasmic  eosinophilia  and  the  presence
f  pyknotic  homogenous  nucleus,  the  ischemic  neurons  were
valuated  as  Grade  O  =  ischemic  neurons,  Grade  1  =  presence
f  ischemic  neurons  less  than  10%,  Grade  2  =  presence
f  ischemic  neurons  between  10%  and  50%  and  Grade
 =  presence  of  ischemic  neurons  more  than  50%  according
o  the  frequency  of  ischemic  neurons  in  CA  1.
The  brains  from  rats  in  all  groups  were  given  code  num-
ers  and  put  into  bottles  containing  4%  formaldehyde  in
rder  to  ensure  ﬁxation.  Then  the  tissues  were  washed  under
treaming  water  and  passed  through  respectively  70%,  80%,
6%  and  100%  alcohol  series  for  dehydration.  In the  next
tep,  the  tissues  were  passed  through  xylene  series  for  trans-
arency.  Finally,  they  were  kept  in  parafﬁn  at  60 ◦C  heated
ven  and  embedded  into  parafﬁn  blocks.5  m-thick  slices
ere  taken  from  the  parafﬁn  blocks  obtained  and  kept  in
n  oven  at  60 ◦C  for  duration  of  45  min.  Then,  they  were
assed  through  xylene  for  2  times  and  graded  alcohol  series
or  4  times  (respectively  100%,  96%,  80%,  70%);  washed  in
treaming  water  and  plunged  into  acid  alcohol  after  being
tained  with  hematoxylin  for  30  s.  Then  they  were  stained
ith  eosin  for  1  min,  washed  again  and  treated  with  xylene
fter  passing  through  the  series  of  alcohol.  At  the  last  stage,
ntellan  (Merc)  was  dropped  on  them  and  they  were  put
nder  lamella.  Then,  stereological  counting  was  started.
Based  on  the  data  obtained  from  two-dimensional  projec-
ions  of  three-dimensional  objects,  stereology  is  a  discipline
hat  enables  us  to  obtain  information  on  real  properties  and
umerical  values  of  biological  structures  (size,  number,  sur-
ace  area,  volume,  etc.).20 There  are  several  methods  used
n  stereology.  Among  them  is  the  fractionator  method  which
e  used  in  our  study.  Through  this  method,  we  can  learn
any  details  about  the  structure  on  hand  (surface  area,  den-
ity,  etc.).  In  this  study,  we  calculated  the  numerical  density
f  neurons  for  all  groups.20
The  slices  ready  for  analysis  were  examined  under  the
ight  microscope  with  Olympus  BH  40  brand  camera  attach-
ent  and  the  photographs  of  all  relevant  groups  were  taken.
n  this  study,  we  used  fractionator  method,  which  is  one  of
tereological  methods,  as  well  as  unbiased  counting  frame
nd  Stereo  Investigator  (version  6.0,  Micro  Bright  Field,
olchester,  VT)  with  special  software.  The  said  appara-
us  consists  of  a  microscope  camera,  a  motorized  systems
oving  the  microscope  table  and  a  computer  contain-
ng  software  to  control  their  use.  In  the  study,  the  slices
btained  from  each  animal  were  placed  in  the  microscope
able  and  the  contours  of  the  area  (cortex)  on  which  we  will
ake  measurements  were  drawn  with  the  help  of  a  programhrough  2.5×  magniﬁcation.  After  determining  the  areas  to
e  measured,  the  systematic  random  sampling  command
as  given  to  the  apparatus  at  a  magniﬁcation  of  40.  Accord-
ng  to  this  command,  the  step  intervals  were  determined  as
Dexmedetomidine’s  and  thiopental’s  cerebral  protective  effects
Figure  5  Counted  neurons  are  seen  in  the  unbiased  count-
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7ing frame  at  a  magniﬁcation  of  40  in  the  Stereo-Investigator
(version  6.0,  Micro  Bright  Field,  Colchester,  VT).  Stars  indicate
intact  neurons  and  circles  indicate  necrotic  neurons.
150--150  m  in  the  x--y  plane  and  75  m  ×  75  m  in  the  area
of  the  unbiased  counting  frame.  Then,  the  unbiased  count-
ing  frame  was  placed  onto  the  section  (the  software  in  the
computer  enables  this)  and  the  intact  and  damaged  neurons
in  the  cortex  were  counted  by  using  different  markers  and
in  accordance  with  the  stereological  rules.  Each  animal’s
stereologically  numerical  density  of  neurons  was  calculated
(Fig.  5).
Statistical  analysis
For  statistical  analysis  of  the  data  between  groups,
Windows-compatible  SPSS  (version  10.0)  program  was  used.
Cerebral  ischemia  scores  between  groups  and  the  weights  of
the  subjects  were  statistically  evaluated  using  respectively
chi-square  test  in  the  4  ×  2  contingency  table  and  indepen-
dent  sample  t-test.  ANOVA  (Two  Way  Variance  Analysis)  was
used  for  statistical  evaluation  of  physiological  parameters.
While  comparing  the  groups  with  each  other,  ‘‘p-value’’  was
obtained  and  interpreted  using  the  LSD  (Least  Square  Differ-
ence)  method.  p  <  0.05  was  considered  as  signiﬁcant.
The  data  obtained  by  stereological  views  were  uploaded
to  the  SSPS  version  15.0.  Data  of  the  intact  group  and
that  of  the  necrotic  group  were  compared  with  each  other.
Mann--Whitney  U  test  was  used  for  statistical  analysis.  In  the
comparison  between  the  data  of  intact  group  and  that  of  the
necrotic  group,  it  was  found  to  be  statistically  signiﬁcant  in
three  groups.
Findings
Their  physical  data  of  the  subjects  are  shown  in  Table  1.
No  statistical  difference  was  found  between  the  weights
of  all  subjects  (p  >  0.05).  When  the  table  was  examined  in
detail,  no  statistical  difference  was  found  between  mean
arterial  pressure,  heart  rate,  body  temperature,  hemat-
ocrit,  blood  glucose,  HCT,  PO2,  PCO2 and  pH  at  the  stages
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f  start  before  ischemia  and  occlusion  and  reperfusion  after
schemia  between  the  three  groups  (p  >  0.05).  For  instance,
nitial  values  of  mean  arterial  pressure  were  found  to  be
04.9  ±  6.7  in  the  control  group  (Group  C),  105.1  ±  4.1  in  the
exmedetomidine  group  (Group  D)  and  105.8  ±  5.5  in  the
hiopental  group  (Group  T).  When  compared  statistically,
o  differences  were  observed  in  these  values.  Again,  the
cclusion  values  of  the  mean  arterial  pressure  were  found  to
e  136.9  ±  3.9  in  the  control  group  (Group  C),  37.1  ±  4.1  in
he  dexmedetomidine  group  (Group  D)  and  37.3  ±  3.9  in  the
hiopental  group  (Group  T).  In  reperfusion,  however,  these
alues  were  found  to  be  respectively  96.9  ±  4.4,  95.5  ±  5.2
nd  96.1  ±  4.7.  When  compared  statistically,  no  differences
ere  observed  in  these  values.
Table  1  also  provides  statistical  comparison  of  subjects’
hysiological  values  between  start,  occlusion  and  reper-
usion  values  within  each  group.
It  was  found  out  that  while  the  initial  value  of  the  mean
rterial  pressure  was  found  to  be  104.9  ±  6.7  in  the  con-
rol  group  (Group  C),  it  decreased  to  36.9  ±  3.9  in  occlusion
nd  raised  to  96.9  ±  4.4  again  during  the  reperfusion.  When
he  values  for  this  group  were  statistically  compared,  a
tatistically  signiﬁcant  difference  was  found  between  the
nitial  value  of  the  mean  arterial  pressure  and  that  of  the
cclusion  value  as  well  as  the  value  of  occlusion  and  the
alue  of  reperfusion  (p  <  0.001).  A  signiﬁcant  difference
as  also  found  between  the  initial  value  and  the  value
f  reperfusion  (p  <  0.05).  However,  similar  statistical  dif-
erences  were  found  to  be  between  the  initial,  occlusion
nd  reperfusion  values  of  mean  arterial  pressure  in  the
exmedetomidine  and  thiopental  groups.
While  the  initial  value  of  heart  rate  was  329.3  ±  20.4
n  the  control  group  (Group  C)  329.3  ±  20.4,  they  were
ound  to  have  decreased  to  304.9  ±  23.6  in  occlusion  and
o  311.2  ±  27.3  in  reperfusion.  A  statistically  signiﬁcant  dif-
erence  was  detected  between  the  initial,  occlusion  and
eperfusion  values  of  the  heart  rate  (p  <  0.05).  Again  in  the
exmedetomidine  and  thiopental  groups,  similar  statistical
ifferences  were  found  between  the  initial,  occlusion  and
eperfusion  values  of  the  heart  rate.
It  was  found  out  that  while  the  initial  value  of  the  body
emperature  was  found  to  be  37.89  ±  0.17  in  the  control
roup  (Group  C),  it  decreased  to  36.92  ±  0.14  in  occlusion
nd  reached  to  37.54  ±  0.10  again  during  the  reperfusion.
hen  the  values  for  this  group  were  statistically  compared,
 statistically  signiﬁcant  difference  was  found  between  the
nitial  value  of  the  body  temperature  and  that  of  the  occlu-
ion  value  as  well  as  the  value  of  occlusion  and  the  value  of
eperfusion  (p  <  0.05).  No  signiﬁcant  difference  was  found
etween  the  initial  value  and  the  value  of  reperfusion.
owever,  similar  statistical  differences  were  found  to  be
etween  the  initial,  occlusion  and  reperfusion  values  of
ody  temperature  in  the  dexmedetomidine  and  thiopental
roups.
It  was  found  out  that  while  the  initial  value  of  pO2
as  found  to  be  92.1  ±  3.3  in  the  control  group  (Group
),  it  decreased  to  54.2  ±  3.8  in  occlusion  and  reached  to
7.2  ±  4.2  again  during  the  reperfusion.  When  the  values
or  this  group  were  statistically  compared,  a  statistically
igniﬁcant  difference  was  found  between  the  initial  value
f  the  pO2 and  that  of  the  occlusion  value  as  well  as  the
alue  of  occlusion  and  the  value  of  reperfusion  (p  <  0.001).
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 signiﬁcant  difference  was  also  observed  between  the  ini-
ial  value  and  the  value  of  reperfusion  (p  <  0.001).  Again,
imilar  statistical  differences  were  found  to  be  between
he  initial,  occlusion  and  reperfusion  values  of  pO2 in  the
exmedetomidine  and  thiopental  groups.
It  was  found  out  that  while  the  initial  value  of  pCO2
as  found  to  be  35.7  ±  1.6  in  the  control  group  (Group
),  it  reached  to  40.2  ±  1.2  in  occlusion  and  decreased  to
7.5  ±  1.7  again  during  the  reperfusion.  When  the  values  for
his  group  were  statistically  compared,  a  statistically  signif-
cant  difference  was  found  between  the  initial  value  of  the
CO2 and  that  of  the  occlusion  value  as  well  as  the  value  of
cclusion  and  the  value  of  reperfusion  (p  <  0.01).  A  signiﬁ-
ant  difference  was  also  observed  between  the  initial  value
nd  the  value  of  reperfusion  (p  <  0.05).  Again,  similar  sta-
istical  differences  were  found  to  be  between  the  initial,
cclusion  and  reperfusion  values  of  pCO2 in  the  dexmedeto-
idine  and  thiopental  groups.
It  was  found  out  that  while  the  initial  value  of  glucose
as  found  to  be  135.4  ±  2.7  in  the  control  group  (Group
),  it  reached  to  142.9  ±  1.6  in  occlusion  and  decreased  to
39.7  ±  1.9  again  during  the  reperfusion.  When  the  values
or  this  group  were  statistically  compared,  a  statistically
igniﬁcant  difference  was  found  between  the  initial  value
f  the  glucose  and  that  of  the  occlusion  value  as  well  as  the
alue  of  occlusion  and  the  value  of  reperfusion  (p  <  0.01).  A
igniﬁcant  difference  was  also  observed  between  the  initial
alue  and  the  value  of  reperfusion  (p  <  0.05).  Again,  sim-
lar  statistical  differences  were  found  to  be  between  the
nitial,  occlusion  and  reperfusion  values  of  glucose  in  the
exmedetomidine  and  thiopental  groups.
While  the  initial  value  of  Hct  was  found  to  be  37.4  ±  2.1  in
he  control  group  (Group  C),  it  was  observed  to  be  37.5  ±  2.4
n  occlusion  and  38.6  ±  1.9  in  reperfusion.  No  statistically
igniﬁcant  difference  was  found  between  the  initial,  occlu-
ion  and  reperfusion  values  of  Hct  (p  >  0.05).  Again,  similar
tatistical  differences  were  found  to  be  between  the  initial,
cclusion  and  reperfusion  values  of  Hct  in  the  dexmedeto-
idine  and  thiopental  groups  (Table  1).
istopathological  scores
istopathological  scores  of  all  the  three  groups  are  shown  in
ig.  6.  According  to  the  histopathological  score,  there  was
schemia  in  all  subjects  in  the  Group  C.  There  was  no  cere-
ral  ischemia  in  4  subjects  in  the  Group  D  and  in  3  subjects
n  the  Group  T.  While  Grade  1  cerebral  ischemia  was  found
o  be  in  2  subjects  in  the  Group  C  and  in  4  subjects  in  the
roup  D,  it  was  observed  in  5  subjects  in  Group  T.  Grade
 cerebral  ischemia  was  only  found  in  3  subjects  in  Group
 and  in  one  subject  in  Group  D  and  Group  T.  Yet,  Grade  3
erebral  ischemia  was  found  in  3  subjects  in  Group  C  and
nly  in  one  subject  in  Group  D  and  Group  T.
No  statistically  signiﬁcant  difference  was  observed
etween  Group  D  and  Group  T  in  terms  of  histopathological
cores  (p  >  0.05).  However,  a  statistically  signiﬁcant  differ-
nce  was  found  between  Group  C  and  Group  D  (p  <  0.05)  and
roup  C  and  Group  T  (p  <  0.01)  in  this  respect.
The  microscopic  images  of  score  obtained  through
istopathologic  examination  are  shown  in  Fig.  6  (Grade  0,
rade  1,  Grade  2  and  Grade  3).
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tereological  results
n  Fig.  7,  the  numerical  density  of  necrotic  neurons  in
he  control  group  as  well  as  in  the  groups  treated  with
exmedetomidine  and  thiopental.  In  the  study,  it  was
bserved  that  the  average  numerical  density  of  necrotic
eurons  was  very  high  in  the  control  group  (0.00047  n/m3)
hile  it  was  less  in  the  groups  treated  with  dexmedetomi-
ine  (0.00044  n/m3)  and  thiopental  (0.00044  n/m3).
In  Fig.  8,  numerical  density  of  intact  neurons  was
iven  for  the  control  group  and  the  groups  treated
ith  dexmedetomidine  and  thiopental.  The  number  of
ntact  neurons  was  observed  to  be  (0.00055  n/m3)  in
he  group  treated  with  dexmedetomidine  and  higher
0.00053  n/m3)  in  the  group  treated  with  thiopental  while
ess  (0.00038  n/m3)  in  the  control  group.
iscussion
n  order  to  create  experimentally  the  most  realistic  cerebral
schemia  model,  various  techniques22,25 were  created  from
arious  animal  groups.21--25 In  our  study,  we  preferred  to  use
ats  for  obvious  reasons  such  that  their  cerebral  circulatory
ystem  is  very  similar  to  that  of  humans  and  they  are  readily
vailable  and  inexpensive.
In  this  study,  the  neck  region  of  the  subjects  in  the  supine
osition  in  supine  position  was  shaved  and  the  sterilization
f  the  surgical  site  was  achieved.  Their  heads  were  slightly
xtended  and  the  midline  pretracheal  surgical  incision  was
ade.  Reaching  the  trachea,  the  right  carotid  artery  in  the
osterolateral  of  the  trachea,  vagus  nerve  and  cervical  sym-
athetic  plexus  were  maintained  and  then  explored  and,
hey  were  ﬁxed  with  a  suture  for  being  clamped  subse-
uently.  5  min  after  administrating  30  units  of  heparin  for
he  purpose  of  anticoagulation,  about  3--5  mL  of  blood  was
ollected  in  a  controlled  manner  through  injector  from  the
emoral  artery  in  order  to  produce  hemorrhagic  hypoten-
ion.  Carotid  arteries  was  occluded  with  vascular  clamp  for
 duration  of  45  min  when  mean  arterial  pressure  (MAP)
eached  to  35  mmHg.  During  this  period,  MAP  was  kept  ﬁxed
t  35--40  mmHg.  The  clamps  were  removed  at  the  end  of  the
eriod  and  brain  reperfusion  was  achieved  for  90  min.
In  clinical  practice,  the  importance  of  ischemia  has  led
esearchers  to  create  and  develop  experimental  models
or  cerebral  ischemia.  In  various  models  applied,  whole  or
egional,  complete  or  incomplete  and  permanent  or  tempo-
ary  ischemia  were  produced.
The  models  applied  may  cause  a  permanent  or  tran-
ient  ischemia;  among  the  methods  applied  in  the  model,
ntravascular  embolization  or  extravascular  ligation  may
e  used  and  the  occlusion  of  Arteria  Cerebralis  Media
ACM)  may  be  produced  through  bipolar  coagulation.24--29
hrough  the  intravascular  embolization  technique,  focal,
ermanent  ischemia  can  be  obtained  without  having  to
raniectomy,  however,  It  is  impossible  to  determine  the
ocalization  of  embolism  and  generally,  multifocal  infarct
reas  are  developed  in  different  widths  and  locations.27
n  extravascular  ligation  techniques,  obtaining  a  focal  and
ermanent  ischemia  is  relatively  hard  and  often  requires
nvasive  procedures.28,29
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Table  1  All  subjects’  weights,  mean  arterial  pressures  5  min  before  ischemia  and  during  occlusion  and  reperfusion,  heart  rate,
body temperature,  pH,  PO2,  PCO2,  glucose  and  hematocrit  values  and  their  statistical  comparison.
Variables  Group  C  (n  =  10)
(Control)
Group  D  (n  =  10)
(Dexmedetomidine)
Group  T  (n  =  10)
(Thiopental)
p  value
Weight  308.3  ±  9.9  312.9  ±  13.8  311.3  ±  11.3  >0.05
Mean arterial  pressures
Initial  value  104.9  ±  6.7c,g 105.1  ±  4.1c,g 105.8  ±  5.5c,g >0.05
Occlusion 36.9  ±  3.9f 37.6  ±  4.1f 37.3  ±  3.9f >0.05
Reperfusion  96.9  ±  4.4  95.5  ±  5.2  96.1  ±  4.7  >0.05
Heart rate
Initial  value 329.3  ±  20.4a 324.5  ±  19.2a 332.2  ±  21.1a >0.05
Occlusion 304.6  ±  23.6 304.6  ±  24.9  304.6  ±  28.2  >0.05
Reperfusion  311.2  ±  27.3  311.2  ±  22.8  311.2  ±  26.6  >0.05
Body temperature
Initial  value  37.89  ±  0.17a 37.91  ±  0.14a 37.82  ±  0.11a >0.05
Occlusion 36.92  ±  0.14d 36.09  ±  0.12d 36.71  ±  0.15d >0.05
Reperfusion 37.54  ±  0.10  37.62  ±  0.11  37.72  ±  0.09  >0.05
pH
Initial value  7.37  ±  0.03  7.37  ±  0.04  7.38  ±  0.04  >0.05
Occlusion 7.21  ±  0.07  7.23  ±  0.05  7.20  ±  0.06  >0.05
Reperfusion  7.34  ±  0.04  7.35  ±  0.06  7.36  ±  0.07  >0.05
PO2 (mmHg)
Initial  value  92.1  ±  3.3c,g 94.4  ±  3.9c,g 91.9  ±  4.9c,g >0.05
Occlusion 54.2  ±  3.8e 52.9  ±  4.6e 53.7  ±  3.6e >0.05
Reperfusion  77.2  ±  4.2  76.8  ±  5.1  77.4  ±  4.4  >0.05
PCO2 (mmHg)
Initial  value  35.7  ±  1.6b,g 36.1  ±  0.9b,g 35.6  ±  1.3b,g >0.05
Occlusion 40.2  ±  1.2d 40.7  ±  1.1d 40.6  ±  0.9d >0.05
Reperfusion  37.5  ±  1.7  37.4  ±  1.6  37.1  ±  1.2  >0.05
Glucose (mg/dL)
Initial  value  135.4  ±  2.7b,g 137.4  ±  3.1b,g 138.4  ±  2.4b,g >0.05
Occlusion 142.9  ±  1.6d 143.8  ±  2.8d 144.1  ±  2.2d >0.05
Reperfusion  139.7  ±  1.9  139.4  ±  2.4  140.7  ±  1.5  >0.05
HCT
Initial value  37.4  ±  2.1  37.6  ±  1.9  37.8  ±  2.1  >0.05
Occlusion 37.5  ±  2.4  37.5  ±  2.3  37.5  ±  1.8  >0.05
Reperfusion  38.6  ±  1.9  38.8  ±  2.2  38.5  ±  2.4  >0.05
Signiﬁcant differences between the values at the beginning and during occlusion. ap < 0.05, bp < 0.01 ve cp < 0.001.
Signiﬁcant differences between the values during occlusion and reperfusion. dp < 0.05 ve ep < 0.01, fp < 0.001.
Signiﬁcant differences between the values at the beginning and during reperfusion. gp < 0.05, hp < 0.01, ip < 0.001.
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bACM  occlusion  in  rats  leads  to  the  formation  of  focal  cere-
bral  ischemia  followed  by  a  infarct  region.  ACM  occlusion
has  been  widely  used  since  1975.27 This  model  was  used  for
many  times  in  the  focal  cerebral  ischemia  studies  and  has
already  proven  itself.24--29
In  order  to  eliminate  the  confusion  that  may  occur
during  interpretation  of  the  results  obtained  from  incom-
plete  cerebral  ischemia;  the  subjects  in  all  three  groups
receive  the  same  anesthetic  agents  until  the  end  of  a.carotis
unilateral  communis  occlusion  (the  end  of  ischemia).  All  sub-
jects  in  our  study  underwent  isoﬂurane  anesthesia  until  the
end  of  unilateral  arteriacarotiscommunis  occlusion  due  to
the  presence  of  studies  indicating  that  isoﬂurane  has  no
f
I
r
wistopathologically  protective  effect  after  incomplete  cere-
ral  ischemia.
Among  the  three  groups  in  this  study,  no  statistical  differ-
nce  was  found  between  mean  arterial  pressure,  heart  rate,
ody  temperature,  hematocrit,  blood  glucose,  hcT,  pO2,
CO2 and  pH  at  the  stages  of  start  before  ischemia  and  occlu-
ion  and  reperfusion  after  ischemia.  The  fact  that  the  mean
hysiologic  values  of  the  laboratory  animals  were  found  to
e  similar  at  the  initial,  post-ischemia  occlusion  and  reper-
usion  stages  is  an  indiction  of  the  homogeneity  of  groups.
n  a  number  of  studies,  the  initial  values  of  the  groups  were
eported  to  be  similar.14,15,20 For  instance,  in  their  studies
here  they  compared  early  focal  cerebral  ischemic  Injury
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Grade 3
Histopathological scores
∗
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Figure  6  Histopathological  score  results  in  the  Hippocampus  cornuammonis  1  (CA  1)  Area:  Grade  0  (yellow)  =  no  ischemic  neurons,
Grade 1  (green)  =  presence  of  ischemic  neurons  less  than  10%,  Grade  2  (blue)  =  presence  of  the  ischemic  neurons  between  10  and
50%, Grade  3  (red)  =  presence  of  ischemic  neurons  more  than  50%  (*p  <  0.01  between  Group  C  and  Group  D  and  Group  C  and  Group  T).
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tigure  7  Numerical  density  of  necrotic  neuron  in  the  con-
rol group  and  the  groups  treated  with  dexmedetomidine  and
hiopental.
n  rats  with  thiopental  and  methoheksital  and  pentobarbi-
al  controls,  Cole  et  al.14 found  that  the  initial  values  of
H,  PaO2,  PaCO2,  mean  arterial  pressure,  hematocrit  and
lucose  levels  were  similar  in  all  4  groups  they  studied.
On  the  other  hand,  Drummond  et  al.11 could  not  detect
ny  differences  in  initial  physiological  parameters  of  4
roups  in  their  studies  where  they  compared  the  cerebral
rotective  properties  of  etomidate,  isoﬂurane,  and  thiopen-
al.  The  above  results  seem  to  verify  the  results  of  this
tudy.
In  this  study,  the  mean  arterial  pressure,  body  tem-
erature,  heart  rate,  pH  and  PO2 values  were  found  to
igniﬁcantly  decrease  in  the  occlusion  and  raised  again  in
he  reperfusion  in  three  groups  when  compared  to  the  ini-
ial  values.  However,  glucose  and  pCO2 values  were  found  to
aise  in  the  occlusion  and  decrease  again  in  the  reperfusion
n  three  groups  when  compared  to  the  initial  values.
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iigure  8  Numerical  density  of  intact  neurons  in  the  con-
rol group  and  the  groups  treated  with  dexmedetomidine  and
hiopental.
Kuhmonen  et  al.30 studied  the  effects  of  dexmedetomi-
ine  after  temporary  and  permanent  occlusion  of  middle
erebral  artery  in  rats.  They  administered  0.9%  NaCl
ntravenously  to  the  control  group;  these  researchers
eported  that  mean  arterial  pressure,  PO2 and  PCO2 values
ecreased  after  ischemia  in  both  temporary  and  permanent
cclusal  groups,  however,  the  pH  and  body  temperature
emained  the  same.  Nevertheless,  they  found  that  the  glu-
ose  increased.
Engelhard  et  al.31 showed  that,  in  the  two  medicament
roups  and  control  groups,  the  mean  arterial  pressure  and
lucose  values  decreased  in  ischemia  compared  to  the  ini-
ial  values,  however,  they  raised  again  in  the  reperfusion.
till,  the  level  of  pCO2 was  found  to  increase  compared  to
ts  initial  value  and  then,  decreased  to  its  initial  value  during
allen  reperfusion.  Engelhard  at  al.,32 in  another  study,  stud-
ed  the  -2  agonist  dexmedetomidine’s  effects  on  cerebral
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neurotransmitter  concentrations  during  cerebral  ischemia
in  rats.  In  their  studies,  they  demonstrated  that  the  mean
arterial  pressure  value  decreased  in  ischemia  compared  its
initial  value  and  then,  raised  again  in  the  reperfusion.
Jolkkonen  et  al.15 researched  in  their  in  vitro  studies
the  effects  of  dexmedetomidine,  NBQX  and  CGS-19755  after
the  occlusion  and  reperfusion  of  middle  cerebral  artery
according  to  an  infarct  volume.  They  administered  0.9%  NaCl
intravenously  to  the  control  group.  They  found  the  initial
values  of  the  mean  arterial  pressure,  PO2,  PaCO2,  pH  and  of
glucose  similar  in  all  the  four  groups.  They  also  found  that
PO2 and  PaCO2 decreased  during  occlusion  and  reperfusion
in  all  groups  while  raising  in  the  dexmedetomidine  group.
The  results  of  this  study  and  the  results  of  the  above  studies
were  found  to  be  partially  in  compliance.
The  cause  of  the  cerebral  ischemia  is  the  increase  in
catecholamine  concentration  in  the  circulation  and  the
extracellular  space.  The  inventions  reducing  sympathetic
tonus  improves  neurological  outcome.33,34 Therefore,  a
treatment  administered  with  agents  that  reduce  the  release
of  norepinephrine  in  the  brain  (i.e.  2-agonists)  may  pro-
vide  protection  against  the  damaging  effects  of  cerebral
ischemia.  It  has  been  showed  in  numerous  studies  con-
ducted,  that  dexmedetomidine  improves  neuronal  survival
in  transient  global  or  focal  ischemia  in  rats.16,30,35 The
mechanism  concerning  the  neuroprotective  effect  of  2-
agonists  is  not  clear  yet.  Engelhard  et  al.  has  demonstrated
that  dexmedetomidine  does  not  suppress  cerebral  extracel-
lular  catecholamine  increase  during  ischemia  and  argued
that  the  neuroprotective  effect  of  dexmedetomidine  results
from  modulation  of  the  balance  between  proapoptotic  and
anti-apoptotic  proteins.31,32 Many  studies  has  shown  that  2-
adrenoceptoragonists  decrease  the  excitatory  neurotrans-
mitter  release  (i.e.,  glutamate).36,37 As  is  known,  high  gluta-
mate  levels  depolarizes  the  neuronal  membrane  and  allows
calcium  to  get  into  the  cell.  And  this  triggers  a  series  of
events  causing  cellular  damage.  Therefore,  agents  reducing
glutamate  release  are  considered  to  be  neuroprotective.
It  has  been  observed  that  administration  of  dexmedeto-
midine  in  focal  cerebral  ischemia  reduces  infarct  volume
by  40%  in  the  cortex,  and  causes  minimal  hyperglycemia
and  hypotension.15 In  incomplete  cerebral  ischemia,  it  was
observed  that,  through  administration  of  dexmedetomidine,
a  decrease  occurred  in  the  plasma  catecholamine  level  and
histopathological  improvement  became  better  than  control,
depending  on  the  dose.16 A  decrease  by  31%  in  the  cortex  and
20%  in  the  striatum  was  reported  in  the  infarct  volume  after
transient  occlusion  (15  g  kg−1)  in  rats  given  a  high  dose
of  dexmedetomidine.17 It  was  reported  that,  during  cere-
bral  ischemia,  circulating  catecholamine  decreased  while
noradrenaline  and  glutamate  concentrations  in  the  brain
remained  unaffected  by  dexmedetomidine.18 In  addition,
dexmedetomidine  was  reported  to  have  a neuroprotective
effect  in  the  neonatal  period  and  to  prevent  excitotoxic
lesions  in  the  cortex  and  white  matter.19 Similarly,  there
are  many  studies  indicating  that  barbiturates  reduce  the
spread  of  brain  injuria  as  a  result  of  transient  focal  cerebral
ischemia.  While  some  researchers  has  stated  that  thiopental
has  a  protective  effect14,20 some  other  reported  that  it  has
no  protective  effects.21,38
This  study  was  designed  to  examine  whether  thiopen-
tal  and  dexmedetomidine  which  are  among  the  intravenous
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nesthetics  have  cerebral  protective  effects  in  focal
erebral  ischemia  in  rats  and  which  medication  has  the  most
rotective  effect.
According  to  the  histopathological  score,  there  was
schemia  in  all  subjects  in  the  control  group.  There  was
o  cerebral  ischemia  in  4  subjects  in  the  dexmedetomi-
ine  group  and  in  3  subjects  in  the  thiopental  group.  While
rade  1  cerebral  ischemia  was  present  in  2  subjects  in
he  control  group  and  in  4  subjects  in  the  dexmedetomi-
ine  group,  it  was  observed  in  5  subjects  in  the  thiopental
roup.  Grade  2  cerebral  ischemia  was  found  to  be  in  3  sub-
ects  in  the  control  group  and  only  in  one  subject  in  the
exmedetomidine  and  thiopental  group.  Still,  Grade  3 cere-
ral  ischemia  was  found  to  be  in  3  subjects  in  the  control
roup  and  only  in  one  subject  in  the  dexmedetomidine  and
hiopental  group.  There  was  no  statistically  signiﬁcant  dif-
erence  between  dexmedetomidine  and  thiopental  group  in
erms  of  histopathological  scores.  However,  there  was  a  dif-
erence  between  the  control  group  and  these  two  groups
dexmedetomidine  group  and  thiopental  group).
Cole  et  al.14 used  6--20  week-old  80  male  rats  weigh-
ng  375--425  g  in  their  studies  in  which  they  compared
hiopental,  methoheksital  and  pentobarbital  controls  in
arly  focal  cerebral  ischemic  injure.  During  this  study,  EEG
as  continuously  recorded  through  platinum  needles  placed
n  the  bitemporal  conﬁguration.  A  two-part  medication
egimen  was  administered  to  rats.  This  ﬁrst  part  of  the
tudy  (EEG  burst-suppression)  was  performed  on  40  rats.
ach  group  consisted  of  10  rats.  0.9%  NaCl  was  administered
ntravenously  to  the  controls.  As  a  result  of  this  part,
he  volume  of  cerebral  injure  was  found  to  be  similar  in
he  control  group  (133  ±  17  mm3),  in  the  methoheksital
roup  (126  ±  19  mm3) and  in  the  pentobarbital  group
130  ±  17  mm3).  However,  a  lower  cerebral  injure  volume
as  detected  in  the  thiopental  group  (88  ±  14  mm3).  In
ther  words,  thiopental  was  observed  to  have  the  most  pro-
ective  effect  that  reduces  the  volume  of  cerebral  injury.
n  contrast,  in  the  second  part  of  the  study  conducted  with
arbiturates  at  a  dose  of  40%,  they  signiﬁcantly  reduced
nly  the  infarct  volume  of  methoheksital  group  among  the
roups  created  similarly.  As  a  result  of  the  second  part  of
he  study,  the  volume  of  cerebral  injure  was  found  to  be
imilar  in  the  control  group  (124  ±  22  mm3),  in  the  thiopen-
al  group  (118  ±  15  mm3)  and  in  the  pentobarbital  group
121  ±  20  mm3).  However,  a  lower  volume  of  cerebral  injure
as  detected  in  the  methoheksital  group  (70  ±  20  mm3).
Drummond  et  al.21 has  compared  the  cerebral  protec-
ive  properties  of  etomidate,  isoﬂurane  and  thiopental.
fter  inserting  vascular  catheter,  they  divided  the  350--400  g
6--20  week-old  male  spontaneously  hypertensive  rats  into
 groups.  8  rats  were  administered  thiopental  IV  (25  mg/mL)
hile  8  rats  were  administered  etomidate  (125  mg/mL)
nd  other  8  rats  were  administered  isoﬂurane.  The  control
roup,  on  the  other  hand,  consisted  of  0.92%  halothane.  The
olume  in  the  cerebral  injure  was  found  to  be  (99  ±  13  mm3)
n  the  halothane  (control)  group,  (56  ±  10  mm3) in  the
hiopental  group,  (139  ±  14  mm3) in  the  isoﬂurane  group
nd  (145  ±  11  mm3)  in  the  etomidate  group.  The  brain  vol-
me  injured  was  signiﬁcantly  the  smallest  in  the  thiopental
roup  compared  to  all  groups.  In  other  words,  thiopental  was
bserved  to  have  the  most  protective  effect  that  reduces  the
olume  of  cerebral  injury.
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Elsaesser  et  al.39 administered  halothane  to  30  Sprague-
awley  rats  by  creating  an  occlusion  of  the  middle  cerebral
rtery.  They  also  administered  intravenously  low  and  high-
ose  thiopental  to  the  other  two  groups.  They  evaluated
he  infarct  volume  after  3  h  of  reperfusion.  When  they  com-
ared  them  with  the  controls,  they  have  found  that  low-dose
hiopental  reduced  the  infarct  volume  by  28%  and  the  high-
ose  thiopental  reduced  the  infarct  volume  by  29%.  The
uthors  have  indicated  that  thiopental  has  cerebral  pro-
ection  and  there  is  no  need  for  extremely  high  doses  in
roviding  this.
Xue  et  al.40 created  brain  ischemia  through  oxygen-
lucose  deprivation  (OGD)  model  in  cerebral  cortical  slices
n  male  Sprague-Dawley  rats  weighting  90--120  g.  They  com-
ared  the  effects  of  ketamine,  midazolam,  thiopental  and
ropofol  on  this  cerebral  ischemia.  The  evaluated  the  slices
y  ELISA  method.  These  researchers  have  found  out  that
hese  4  different  IV  anesthetics  has  different  effects,  low
nd  high  doses  of  ketamine  inhibits  OGD  Injury,  high  doses
f  midazolam  (10  mol/L)  and  thiopental  (400  mol/L)  sup-
ort  partially  this  decrease  and  again,  high  dose  of  propofol
100  mol/L)  also  promotes  this  decrease.  As  a  conclusion,
hey  have  reported  that  ketamine,  midazolam  in  high  doses
nd  thiopental  have  neuroprotective  effects  on  OGD  injuria
n  the  cortical  slices  of  the  rats.
Lianhua  et  al.41 exposed  male  Sprague-Dawley  rats  to  24  h
eperfusion  and  3  h  middle  cerebral  artery  occlusion.  Then,
hey  compare  the  infarct  volume  in  rats’  brains  through  giv-
ng  them  midazolam,  thiopental  and  propofol.  The  discussed
he  neurological  outcomes  over  a  0--5  grading  system.  They
ave  observed  that  ischemic  score  was  relatively  low  in  the
ats  to  which  midazolam  and  propofol  were  administered.
hus,  they  have  reported  that  midazolam  and  propofol  have
rotective  effects  against  reperfusion  injury  but  thiopental
hows  no  protective  effect.
In  conclusion,  we  histopathologically  discussed  whether
hiopental  and  dexmedetomidine  which  are  among  the  intra-
enous  anesthetics  have  cerebral  protective  effects  on  focal
erebral  ischemia  in  rats.  We  have  detected  that  thiopental
nd  dexmedetomidine  are  more  neuroprotective  compared
o  the  controls.  We  have  shown  in  the  experimental  model
f  focal  cerebral  ischemia  in  rats  that  dexmedetomidine
nd  thiopental  have  histopathologically  cerebral  protective
ffects.  However,  the  clinical  accuracy  of  these  effects  is
ot  clear  yet.  Further  studies  are  needed  with  regard  to
he  use  of  dexmedetomidine  and  thiopental  in  appropriately
elected  patient  populations  and  speciﬁc  procedures.
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